1. Home
  2. IDYA vs ANDE Comparison

IDYA vs ANDE Comparison

Compare IDYA & ANDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.94

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Logo Andersons Inc. (The)

ANDE

Andersons Inc. (The)

HOLD

Current Price

$65.19

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
ANDE
Founded
2015
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.3B
IPO Year
2019
2005

Fundamental Metrics

Financial Performance
Metric
IDYA
ANDE
Price
$31.94
$65.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
2
Target Price
$51.21
$75.00
AVG Volume (30 Days)
757.3K
266.3K
Earning Date
05-19-2026
05-20-2026
Dividend Yield
N/A
1.24%
EPS Growth
61.90
12.93
EPS
N/A
0.82
Revenue
$218,710,000.00
$11,008,928,000.00
Revenue This Year
N/A
$13.28
Revenue Next Year
$97.58
$5.76
P/E Ratio
N/A
$79.09
Revenue Growth
3024.43
N/A
52 Week Low
$13.45
$31.03
52 Week High
$39.28
$70.06

Technical Indicators

Market Signals
Indicator
IDYA
ANDE
Relative Strength Index (RSI) 45.48 56.89
Support Level $29.15 $62.90
Resistance Level $33.64 $70.06
Average True Range (ATR) 1.47 2.23
MACD 0.10 -0.63
Stochastic Oscillator 59.47 31.98

Price Performance

Historical Comparison
IDYA
ANDE

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

Share on Social Networks: